Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    i-crest
Show Display Options
Rank Status Study
1 Withdrawn Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors
Conditions: Metastatic Non-Small Cell Lung Cancer;   Metastatic Colon Cancer;   Metastatic Triple Negative Breast Cancer
Interventions: Drug: CTLA-4 Antibody;   Radiation: Hypofractionated Radiotherapy

Study has passed its completion date and status has not been verified in more than two years.